H2020
TransBioLine
Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
- Programme
- Horizon 2020
- Started
- Ends
- Duration
- 72 months
- Total cost
- EUR 27,957,743
- EU contribution
- EUR 13,999,998
- Participants
- 15 from 9 countries
- Topic
- H2020_IMI2-2017-13-11
- Grant agreement
- 821283
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Janssen Pharmaceutica NV | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| Universitaet Bern | CHSwitzerland | Participant | EUR 45,204 | PIC (1.00) |
| Abx Cro Advanced Pharmaceutical Services Forschungsgesellschaft Mbh | DEGermany | Participant | EUR 1,294,360 | PIC (1.00) |
| Charite - Universitaetsmedizin Berlin | DEGermany | Participant | EUR 1,386,194 | PIC (1.00) |
| Metaheps GmbH | DEGermany | Participant | EUR 124,804 | PIC (1.00) |
| Signatope GmbH | DEGermany | Participant | EUR 2,254,000 | PIC (1.00) |
| Servicio Andaluz de la Salud | ESSpain | Participant | EUR 188,946 | VAT number (0.97) |
| assistance publique hopitaux de paris | FRFrance | Participant | EUR 34,000 | name shared with others (0.80) |
| Eli Lilly and Company Ltd | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| The University of Liverpool | GBUnited Kingdom | Participant | EUR 943,125 | PIC (1.00) |
| the university of nottingham | GBUnited Kingdom | Participant | EUR 1,018,028 | known name (0.95) |
| Landspitali University Hospital | ISIceland | Participant | EUR 87,325 | PIC (1.00) |
| Information Technology for Translational Medicine (Ittm) SA | LULuxembourg | Participant | EUR 624,125 | PIC (1.00) |
| Merck Sharp & Dohme Corp | USUnited States | Participant | EUR 0 | PIC (1.00) |
| The Critical Path Institute (C-Path) Non Profit Corporation | USUnited States | Participant | EUR 0 | PIC (1.00) |
Changes of the consortium
First seen on with 15 participants from 9 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.